Effects of vitamin D on serum lipid profile in patients with type 2 diabetes: A meta-analysis of randomized controlled trials

Clinical Nutrition

Volumn 35, Issue 6, 2016, Pages 1259-1268

  Jafari, Tina ^a   Fallah, Aziz A ^b   Barani, Afshin ^c  

^a SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHREKORD UNIVERSITY   (Iran)

^c URMIA UNIVERSITY   (Iran)

Author keywords

Meta analysis; Serum lipid profile; Type 2 diabetes; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CHOLESTEROL; COLECALCIFEROL; DOXERCALCIFEROL; ERGOCALCIFEROL; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PARICALCITOL; TRIACYLGLYCEROL; VITAMIN D; 25-HYDROXYVITAMIN D;

ARTICLE; CHOLESTEROL BLOOD LEVEL; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; DIETARY SUPPLEMENT; FORTIFIED FOOD;

CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FOOD, FORTIFIED; HUMANS; LIPIDS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRIGLYCERIDES; VITAMIN D;

EID: 84961778001     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2016.03.001     Document Type: Article

References (42)

1. [1] International Diabetes Federation, Diabetes: facts and figures. IDF. 2014 Accessed July 8, 2014, at www.idf.org/worlddiabetesday/toolkit/gp/facts-figures.
2. [2] Jafari, T., Fallah, A.A., Azadbakht, L., Role of dietary n-3 polyunsaturated fatty acids in type 2 diabetes: a review of epidemiological and clinical studies. Maturitas 74 (2013), 303–308.
3. [3] Jafari, T., Faghihimani, E., Feizi, A., Iraj, B., Javanmard, S.H., Esmaillzadeh, A., et al. Effects of vitamin D-fortified low fat yogurt on glycemic status, anthropometric indexes, inflammation, and bone turnover in diabetic postmenopausal women: a randomised controlled clinical trial. Clin Nutr 35 (2016), 67–76.
4. [4] Jafari, T., Paknahad, Z., Vitamin D and hypertension. Zahedan J Res Med Sci 16 (2014), 1–7.
5. [5] Rafieian-Kopaei, M., Nasri, H., Vitamin D therapy in diabetic kidney disease. J Nephropharmacol 3 (2014), 3–4.
6. [6] Holick, M.F., Binkley, N.C., Bischoff-Ferrari, H.A., Gordon, C.M., Hanley, D.A., Heaney, R.P., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96 (2011), 1911–1930.
7. [7] Nasri, H., Behradmanesh, S., Maghsoudi, A.R., Ahmadi, A., Nasri, P., Rafieian-Kopaei, M., Efficacy of supplementary vitamin D on improvement of glycemic parameters in patients with type 2 diabetes mellitus; a randomized double blind clinical trial. J Renal Inj Prev 3 (2014), 31–34.
8. [8] Badawi, A., Sayegh, S., Sadoun, E., Al-Thani, M., Arora, P., Haddad, P.S., Relationship between insulin resistance and plasma vitamin D in adults. Diabetes Metab Syndr Obes 7 (2014), 297–303.
9. [9] Pittas, A.G., Lau, J., Hu, F.B., Dawson-Hughes, B., The role of vitamin D and calcium in type 2 diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab 92 (2007), 2017–2029.
10. [10] Wang, H., Xia, N., Yang, Y., Peng, D.Q., Influence of vitamin D supplementation on plasma lipid profiles: a meta-analysis of randomized controlled trials. Lipids Health Dis, 11, 2012, 42.
11. [11] Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gotzsche, P.C., Ioannidis, J.P., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Int Med, 18, 2009 W–65.
12. [12] Jadad, A.R., Moore, R.A., Carroll, D., Jenkinson, C., Reynolds, D.J., Ghavaghan, D.J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996), 1–12.
13. [13] Jafari, T., Feizi, A., Askari, G., Fallah, A.A., Parenteral immunonutrition in patients with acute pancreatitis: a systematic review and meta-analysis. Clin Nutr 34 (2015), 35–43.
14. [14] Atkins, D., Best, D., Briss, P.A., Eccles, M., Falck-Ytter, Y., Flottorp, S., et al. Grading quality of evidence and strength of recommendations. BMJ, 328, 2004, 1490.
15. [15] Cohen, J., A coefficient of agreement for nominal scales. Educ Psychol Meas 20 (1960), 37–46.
16. [16] Viera, A.J., Garrett, J.M., Understanding inter observer agreement: the kappa statistic. Fam Med 37 (2005), 360–363.
17. [17] DerSimonian, R., Laird, N., Meta-analysis in clinical trials. Control Clin Trials 7 (1986), 177–188.
18. [18] Lipsey, M.W., Wilson, D.B., Practical meta-analysis. 2001, Sage Publications, Thousand Oaks, CA.
19. [19] Higgins, J.P.T., Green, S., Cochrane handbook for systematic reviews of interventions. 2008, Wiley & Sons Ltd, West Sussex.
20. [20] Askari, G., Iraj, B., Salehi-Abargouei, A., Fallah, A.A., Jafari, T., The association between serum selenium and gestational diabetes mellitus: a systematic review and meta-analysis. J Trace Elem Med Biol 29 (2015), 195–201.
21. [21] Ioannidis, J., Trikalinos, T., The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. Can Med Assoc J 176 (2007), 1091–1096.
22. [22] Witham, M.D., Dove, F.J., Dryburgh, M., Sugden, J.A., Morris, A.D., Struthers, A.D., The effect of different doses of vitamin D3 on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 53 (2010), 2112–2119.
23. [23] Nikooyeh, B., Neyestani, T.R., Farvid, M., Alavi-Majd, H., Houshiarrad, A., Kalayi, A., et al. Daily consumption of vitamin D- or vitamin D-calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr 93 (2011), 764–771.
24. [24] Tabesh, M., Azadbakht, L., Faghihimani, E., Tabesh, M., Esmaillzadeh, A., Effects of calcium-vitamin D cosupplementation on metabolic profiles in vitamin D insufficient people with type 2 diabetes: a randomised controlled clinical trial. Diabetologia 57 (2014), 2038–2047.
25. [25] Kim, H.J., Kang, C.K., Park, H., Lee, M.G., Effects of vitamin D supplementation and circuit training on indices of obesity and insulin resistance in T2D and vitamin D deficient elderly women. J Exerc Nutr Biochem 18 (2014), 249–257.
26. [26] Jorde, R., Figenschau, Y., Supplementation with cholecalciferol does not improve glycemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr 48 (2009), 349–354.
27. [27] Shab-Bidar, S., Neyestani, T.R., Djazayery, A., Eshraghian, M.R., Houshiarrad, A., Kalayi, A., et al. Regular consumption of vitamin D–fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial. BMC Med, 9, 2011, 125.
28. [28] Muñoz-Aguirre, P., Flores, M., Macias, N., Quezada, A.D., Denova-Gutiérrez, E., Salmerón, J., The effect of vitamin D supplementation on serum lipids in postmenopausal women with diabetes: a randomized controlled trial. Clin Nutr 34 (2015), 799–804.
29. [29] Shehab, D., Al-Jarallah, K., Abdella, N., Mojiminiyi, O.A., Al Mohamedy, H., Prospective evaluation of the effect of short-term oral vitamin D supplementation on peripheral neuropathy in type 2 diabetes mellitus. Med Princ Pract 24 (2015), 250–256.
30. [30] Breslavsky, A., Frand, J., Matas, Z., Boaz, M., Barnea, Z., Shargorodsky, M., Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clin Nutr 32 (2013), 970–975.
31. [31] Rad, E.Y., Djalali, M., Koohdani, F., Saboor-Yaraghi, A.A., Eshraghian, M.R., Javanbakht, M.H., et al. The effects of vitamin D supplementation on glucose control and insulin resistance in patients with diabetes type 2: a ran-domized clinical trial study. Iran J Pub Health 43 (2014), 1651–1656.
32. [32] Yiu, Y.F., Yiu, K.H., Siu, C.W., Chan, Y.H., Li, S.W., Wong, L.Y., et al. Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 227 (2013), 140–146.
33. [33] Al-Zahrani, M.K., Elnasieh, A.M., Alenezi, F.M., Almoushawah, A.A., Almansour, M., Alshahrani, F., et al. A 3-month oral vitamin D supplementation marginally improves diastolic blood pressure in Saudi patients with type 2 diabetes mellitus. Int J Clin Exp Med 7 (2014), 5421–5428.
34. [34] Eftekhari, M.H., Akbarzadeh, M., Dabbaghmanesh, M.H., Hassanzadeh, J., The effect of calcitriol on lipid profile and oxidative stress in hyperlipidemic patients with type 2 diabetes mellitus. ARYA Atheroscler 10 (2014), 82–88.
35. [35] Kampmann, U., Mosekilde, L., Juhl, C., Moller, N., Christensen, B., Rejnmark, L., et al. Effects of 12weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency–a double-blind, randomized, placebo-controlled trial. Metabolism 63 (2014), 1115–1124.
36. [36] Ryu, O.H., Chung, W., Lee, S., Hong, K.S., Choi, M.G., Yoo, H.J., The effect of high-dose vitamin D supplementation on insulin resistance and arterial stiffness in patients with type 2 diabetes. Korean J Intern Med 29 (2014), 620–629.
37. [37] Sadiya, A., Ahmed, S.M., Carlsson, M., Tesfa, Y., George, M., Ali, S.H., et al. Vitamin D supplementation in obese type 2 diabetes subjects in Ajman, UAE: a randomized controlled double-blinded clinical trial. Eur J Clin Nutr 69 (2015), 707–711.
38. [38] Kane, L., Moore, K., Lütjohann, D., Bikle, D., Schwartz, J.B., Vitamin D3 effects on lipids differ in statin and non-statin-treated humans: superiority of free 25-OH D levels in detecting relationships. J Clin Endocrinol Metab 98 (2013), 4400–4409.
39. [39] Oh, J., Weng, S., Felton, S.K., Bhandare, S., Riek, A., Butler, B., et al. 1, 25 (OH) 2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 25:120 (2009), 687–698.
40. [40] Mead, J.R., Irvine, S.A., Ramji, D.P., Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med 80 (2002), 753–769.
41. [41] Vimaleswaran, K.S., Cavadino, A., Hyppönen, E., APOA5 genotype influences the association between 25-hydroxyvitamin D and high density lipoprotein cholesterol. Atherosclerosis 228 (2013), 188–192.
42. [42] Jaimungal, S., Wehmeier, K., Mooradian, A.D., Haas, M.J., The emerging evidence for vitamin D–mediated regulation of apolipoprotein AI synthesis. Nutr Res 31 (2011), 805–812.